Welcome to the UPF Digital Repository
Browsing by Author "Pijuan Andujar, Lara"
- Home
- →
- Browsing by Author
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing by Author "Pijuan Andujar, Lara"
Now showing items 1-19 of 19
-
Badenes Bonet, Diana, 1987-; Pijuan Andujar, Lara; Curull Serrano, Víctor; Sánchez-Font, Albert (Medknow Publications, 2017)Surgicel® (Ethicon, North Ryde, NSW, Australia) is an absorbable sheet of oxidized cellulose polyanhydroglucuronic acid polymer used as an hemostatic in cardiovascular and thoracic surgery. In some cases, the retained ...
-
Conde, Esther; Pijuan Andujar, Lara; Salido Galeote, Marta; Arriola Aperribay, Edurne; Company, Amparo; Lopez-Rios, Fernando (Elsevier, 2019)Introduction: The ROS1 gene rearrangement has become an important biomarker in NSCLC. The College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology testing ...
-
Tang, Jun; Ramis Cabrer, Daniel, 1993-; Curull Serrano, Víctor; Wang, Xuejie; Mateu Jiménez, Mercè, 1990-; Pijuan Andujar, Lara; Duran, Xavier; Qin, Liyun; Rodríguez-Fuster, Alberto; Aguiló Espases, Rafael; Barreiro Portela, Esther (MDPI, 2020)Immune profile of B and T cells and tertiary lymphoid structures (TLSs) may differ in tumors of lung cancer (LC) patients with/without chronic obstructive pulmonary disease (COPD), and may also influence patient survival. ...
-
Bellido, Salomé; Martín-Ontiyuelo, Clara; Pijuan Andujar, Lara; Puig de Dou, Jaume; Suárez-Piñera, Marina; Curull Serrano, Víctor; Sánchez Font, Albert (Elsevier, 2020)
-
Chalela Rengifo, Roberto José, 1985-; Bellosillo Paricio, Beatriz; Curull Serrano, Víctor; Longarón Rozalen, Raquel; Pascual Guàrdia, Sergi, 1979-; Badenes Bonet, Diana, 1987-; Arriola Aperribay, Edurne; Sánchez-Font, Albert; Pijuan Andujar, Lara; Gea Guiral, Joaquim (MDPI, 2019)Tumor recurrence is frequent and survival rates remain extremely low in lung adenocarcinoma (ADC). We hypothesize that carcinogenic factors will promote loco-regional modifications not only in the future tumor, but throughout ...
-
Suárez-Piñera, Marina; Belda, José; Taus García, Álvaro; Sánchez-Font, Albert; Mestre-Fusco, Antoni; Jiménez, Marcel; Pijuan Andujar, Lara (e-Century Publishing, 2018)Quantitative analysis of glucose consumption measured by maximum standardized uptake value (SUVmax) in lung adenocarcinoma (LA) remains in discussion and metabolic information provided by FDG-PET is not included in cancer ...
-
Martín-Ontiyuelo, Clara; Pijuan Andujar, Lara; Sánchez Font, Albert (Elsevier, 2016)n the last years, the endoscopic units introduce the ultrasonic bronchofibrescope with a convex probe that allows for real-time needle aspiration of mediastinal and hilar lymph nodes guided by ...
-
Tang, Jun; Ramis Cabrer, Daniel, 1993-; Curull Serrano, Víctor; Wang, Xuejie; Qin, Liyun; Mateu Jiménez, Mercè, 1990-; Duran Jordà, Xavier, 1974-; Pijuan Andujar, Lara; Rodríguez-Fuster, Alberto; Aguiló Espases, Rafael; Barreiro Portela, Esther (MDPI, 2020)Background: The immune microenvironment plays a role in tumorigenesis. Chronic Obstructive Pulmonary Disease (COPD) is an independent risk factor for lung cancer (LC). We hypothesized that immune profile characterized by ...
-
Tang, Jun; Curull Serrano, Víctor; Wang, Xuejie; Ampurdanés, Coral; Duran, Xavier; Pijuan Andujar, Lara; Rodríguez-Fuster, Alberto; Aguiló Espases, Rafael; Yélamos López, José; Barreiro Portela, Esther (MDPI, 2020)Background: Lung cancer (LC) is a major leading cause of death worldwide. Poly (ADP-ribose) polymerase (PARP)-1 and PARP-2 are key players in cancer. We aimed to assess PARP-1 and PARP-2 expression and activity and DNA ...
-
Alcaraz Mateos, Eduardo; Guerra Pastrián, Laura; Pijuan Andujar, Lara; López Solache, Laura; Zucchiatti, Adriana; García Ángel, Rubén; Prieto Cuadra, Juan Daniel; Labiano Miravalles, Tania; Carvalho, Rita; Gardner, Jerad M.; Terrádez, Cristina; Álava, Enrique de (Elsevier, 2018)INTRODUCCIÓN: La Anatomía Patológica sigue siendo desconocida, no sólo para el público en general sino también para nuestros propios compañeros. El uso generalizado de las redes sociales permite difundir nuestra labor. Por ...
-
Tang, Jun; Ramis Cabrer, Daniel, 1993-; Curull Serrano, Víctor; Mateu Jiménez, Mercè, 1990-; Almagro, Klara; Duran, Xavier; Pijuan Andujar, Lara; Rodríguez-Fuster, Alberto; Aguiló Espases, Rafael; Barreiro Portela, Esther (Elsevier, 2021)Background: Stroma, mainly composed by fibroblasts, extracellular matrix (ECM) and vessels, may play a role in tumorigenesis and cancer progression. Chronic Obstructive Pulmonary Disease (COPD) is an independent risk factor ...
-
Casadevall Aguilar, David; Gimeno Beltran, Javier; Clavé Safont, Sergi; Taus García, Álvaro; Pijuan Andujar, Lara; Arumí de Dios, Miriam; Lorenzo Perez, Marta; Menendez Romero, Silvia; Cañadas Castillo, Israel, 1984-; Albanell Mestres, Joan; Serrano Figueras, Sergi; Espinet Solà, Blanca; Salido Galeote, Marta; Arriola Aperribay, Edurne (Impact Journals, 2015)OBJECTIVE: We aimed to assess MET intratumoral heterogeneity and its potential impact on biomarker-based patient selection as well as potential surrogate biomarkers of MET activation. METHODS: Our study included 120 patients ...
-
Mateu Jiménez, Mercè, 1990-; Fermoselle Pérez, Clara, 1985-; Rojo, Federico; Mateu de Antonio, Francisco Javier; Peña, Raúl; Urtreger, Alejandro J.; Diament, Miriam J.; Joffé, Elisa D. Bal de Kier; Pijuan Andujar, Lara; García de Herreros, Antonio; Barreiro Portela, Esther (Bentham Science Publishers, 2016)Lung cancer (LC) remains the leading cause of cancer mortality worldwide, and non-small cell LC (NSCLC) represents 80% of all LC. Oxidative stress and inflammation, autophagy, ubiquitin-proteasome system, nuclear factor ...
-
Mateu-Jimenez, Mercè; Curull Serrano, Víctor; Rodríguez-Fuster, Alberto; Aguiló Espases, Rafael; Sánchez-Font, Albert; Pijuan Andujar, Lara; Gea Guiral, Joaquim; Barreiro Portela, Esther (BioMed Central, 2018)BACKGROUND: Chronic lung diseases such as chronic obstructive pulmonary disease (COPD) and epigenetic events underlie lung cancer (LC) development. The study objective was that lung tumor expression levels of specific ...
-
Mateu Jiménez, Mercè, 1990-; Sánchez-Font, Albert; Rodríguez-Fuster, Alberto; Aguiló Espases, Rafael; Pijuan Andujar, Lara; Fermoselle Pérez, Clara, 1985-; Gea Guiral, Joaquim; Curull Serrano, Víctor; Barreiro Portela, Esther (BioMed Central, 2016)Chronic respiratory diseases such as obstructive pulmonary disease (COPD) and oxidative stress may underlie lung cancer (LC). We hypothesized that the profile of oxidative and antioxidant events may differ in lung tumors ...
-
Clavé Safont, Sergi; Gimeno Beltran, Javier; Muñoz-Mármol, Ana M.; Vidal Barrull, Joana; Reguart, Noemí; Carcereny, Enric; Pijuan Andujar, Lara; Menendez Romero, Silvia; Taus García, Álvaro; Mate, José Luís; Serrano Figueras, Sergi; Albanell Mestres, Joan; Espinet Solà, Blanca; Arriola Aperribay, Edurne; Salido Galeote, Marta (Impact Journals, 2014)OBJECTIVES: We aimed to determine the prevalence and partners of ROS1 rearrangements, to explore the correlation between FISH and IHC assays, and to investigate clinical implications of ROS1 copy number alterations (CNAs). ...
-
Mateu Jiménez, Mercè, 1990-; Curull Serrano, Víctor; Pijuan Andujar, Lara; Sánchez-Font, Albert; Rivera-Ramos, Hugo; Rodríguez-Fuster, Alberto; Aguiló Espases, Rafael; Gea Guiral, Joaquim; Barreiro Portela, Esther (Elsevier, 2017)INTRODUCTION: Chronic respiratory conditions, especially chronic obstructive pulmonary disease (COPD), and inflammatory events underlie lung cancer (LC). We hypothesized that profiles of T helper 1 and T helper 2 cytokines ...
-
Vazquez de las Heras, Ivonne; Sánchez-Font, Albert; Curull Serrano, Víctor; Pijuan Andujar, Lara (Elsevier, 2018)
-
Garrido, P.; Conde, Esther; De Castro, Javier; Gómez-Román, J. J.; Felip, Enriqueta; Pijuan Andujar, Lara; Isla, Dolores; Sanz, J.; Paz-Ares, L.; López-Ríos, F. (Springer, 2020)In 2011 the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP) started a joint project to establish guidelines on biomarker testing in patients with advanced non-small-cell lung cancer ...
Now showing items 1-19 of 19
© Universitat Pompeu Fabra | Plaça de la Mercè, 10-12. 08002 Barcelona | T. (+34) 93 542 20 00